FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Szekeres

Research Profile

Chemicals & Drugs

Anatomy

Physiology

Co-author Network

Publications

TOP 3
N Kretschy; Sigurd Krieger; A G Atanasov; Verena M Dirsch; Helmut Dolznig; B Giessrigl; Michael Grusch; Nicole Huttary; Walter Jäger; S Kopf; Wolfgang Mikulits; Sebastian M B Nijman; Ingrid Raab; Philipp Saiko; Thomas Szekeres; M Teichmann; K Viola; C Vonach; Georg Krupitza
In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen.
K Viola; C Vonach; S Bauer; R de Martin; Helmut Dolznig; B Giessrigl; Brigitte Hantusch; Nicole Huttary; Walter Jäger; T Keller; S Kopf; N Kretschy; Sigurd Krieger; Georg Krupitza; Wolfgang Mikulits; Ingrid Raab; S Stary; Thomas Szekeres; M Teichmann; Michael Grusch
Bay11-7082 inhibits the disintegration of the lymphendothelial barrier triggered by MCF-7 breast cancer spheroids; the role of ICAM-1 and adhesion.
Georg Wultsch; Oliwia Zakerska; Kambis Atefie; Michael Kundi; Miroslav Mišík; Armen K Nersesyan; Thomas Szekeres; Karl-Heinz Wagner; Siegfried Knasmueller
Formation of micronuclei and other nuclear anomalies in exfoliated nasal and oral cells: results of a human study with workers in a power plant processing poultry litter.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Szekeres (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: N Kretschy; Sigurd Krieger; A G Atanasov; Verena M Dirsch; Helmut Dolznig; B Giessrigl; Michael Grusch; Nicole Huttary; Walter Jäger; S Kopf; Wolfgang Mikulits; Sebastian M B Nijman; Ingrid Raab; Philipp Saiko; Thomas Szekeres; M Teichmann; K Viola; C Vonach; Georg Krupitza
In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen.
British journal of cancer 2013;108(3):570-8.
2013: K Viola; C Vonach; S Bauer; R de Martin; Helmut Dolznig; B Giessrigl; Brigitte Hantusch; Nicole Huttary; Walter Jäger; T Keller; S Kopf; N Kretschy; Sigurd Krieger; Georg Krupitza; Wolfgang Mikulits; Ingrid Raab; S Stary; Thomas Szekeres; M Teichmann; Michael Grusch
Bay11-7082 inhibits the disintegration of the lymphendothelial barrier triggered by MCF-7 breast cancer spheroids; the role of ICAM-1 and adhesion.
British journal of cancer 2013;108(3):564-9.
2013: Georg Wultsch; Oliwia Zakerska; Kambis Atefie; Michael Kundi; Miroslav Mišík; Armen K Nersesyan; Thomas Szekeres; Karl-Heinz Wagner; Siegfried Knasmueller
Formation of micronuclei and other nuclear anomalies in exfoliated nasal and oral cells: results of a human study with workers in a power plant processing poultry litter.
International journal of hygiene and environmental health 2013;216(1):82-7.
2012: Benedikt Giessrigl; Michaela Gollinger; Markus Hengstschläger; Nicole Huttary; Walter Jäger; Egidijus Kazlauskas; Sabine Kopf; Sigurd Krieger; Alexandre Maciuk; Daumantas Matulis; Peter Mazal; Samir Messaoudi; Jean-François Peyrat; Margit Rosner; Philipp Saiko; Thomas Szekeres; Mouad Alami; Georg Krupitza
Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A degradation and cell-cycle attenuation in pancreatic carcinoma cells.
Human molecular genetics 2012;21(21):4615-27.
2012: Mareike Seelinger; Thomas Szekeres; Christine Unger; Bruno Wallnöfer; Ruxandra Popescu; Rene Diaz; Richard Frisch; Monika Fritzer-Szekeres; Benedikt Giessrigl; Walter Jäger; Kanokwan Jarukamjorn; Brigitte Kopp; Georg Krupitza
Methanol extract of the ethnopharmaceutical remedy Smilax spinosa exhibits anti-neoplastic activity.
International journal of oncology 2012;41(3):1164-72.
2012: Christine Unger; Bruno Wallnöfer; Ruxandra Popescu; Lucie Rarova; Mareike Seelinger; Miroslav Strnad; Thomas Szekeres; Rainer de Martin; Rene Diaz; Karel Doležal; Richard Frisch; Monika Fritzer-Szekeres; Benedikt Giessrigl; Michael Grusch; Irene Herbacek; Brigitte Kopp; Georg Krupitza
An apolar extract of Critonia morifolia inhibits c-Myc, cyclin D1, Cdc25A, Cdc25B, Cdc25C and Akt and induces apoptosis.
International journal of oncology 2012;40(6):2131-9.
2012: Max Plischke; Sascha Shayganfar; Guido Strunk; Thomas Szekeres; Patrick Vavken; Christopher Adlbrecht; Christian Bieglmayer; Bernhard Bielesz; Walter H Hörl; Stephanie Neuhold; Richard Pacher; Martin Hülsmann
Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure.
European journal of clinical investigation 2012;42(6):649-56.
2012: Mareike Seelinger; Prapairat Seephonkai; Judith Singhuber; Thomas Szekeres; Foster M Tut; Christine Unger; Karl-Heinz Wagner; Ruxandra Popescu; Sabine Bauer; Rene Diaz; Björn Feistel; Richard Frisch; Monika Fritzer-Szekeres; Benedikt Giessrigl; Brigitte Kopp; Georg Krupitza
Fractionation of an Extract of Pluchea odorata Separates a Property Indicative for the Induction of Cell Plasticity from One That Inhibits a Neoplastic Phenotype.
Evidence-based complementary and alternative medicine : eCAM 2012;2012():701927.
2011: Beate Moser; Armen K Nersesyan; Thomas Szekeres; Karl-Heinz Wagner; Johann Zahrl; Oliwia Zakerska; Christian Bieglmayer; Veronika A Ehrlich; Christine Hoelzl; Nina Kager; Michael Kundi; Miroslav Mišík; Siegfried Knasmueller
Impact of spinach consumption on DNA stability in peripheral lymphocytes and on biochemical blood parameters: results of a human intervention trial.
European journal of nutrition 2011;50(7):587-94.
2011: Sabine Bauer; Judith Singhuber; Mareike Seelinger; Christine Unger; Katharina Viola; Caroline Vonach; Benedikt Giessrigl; Sibylle Madlener; Nicole Stark; Bruno Wallnofer; Karl-Heinz Wagner; Monika Fritzer-Szekeres; Thomas Szekeres; Rene Diaz; Foster Tut; Richard Frisch; Bjorn Feistel; Brigitte Kopp; Georg Krupitza; Ruxandra Popescu
Separation of anti-neoplastic activities by fractionation of a Pluchea odorata extract.
Frontiers in bioscience (Elite edition) 2011;3():1326-36.
2011: Alexandra Maier-Salamon; Thomas Szekeres; Theresia Thalhammer; Michaela Böhmdorfer; Walter Jaeger
Hepatic glucuronidation of resveratrol: interspecies comparison of enzyme kinetic profiles in human, mouse, rat, and dog.
Drug metabolism and pharmacokinetics 2011;26(4):364-73.
2011: Walter Jäger; Alexandra Gruber; Benedikt Giessrigl; Georg Krupitza; Thomas Szekeres; Denise Sonntag
Metabolomic analysis of resveratrol-induced effects in the human breast cancer cell lines MCF-7 and MDA-MB-231.
Omics : a journal of integrative biology 2011;15(1-2):9-14.
2010: Nha T P Vo; Sibylle Madlener; Zsuzsanna Bago-Horvath; Irene Herbacek; Nicole Stark; Manuela Gridling; Paul Probst; Benedikt Giessrigl; Sabine Bauer; Caroline Vonach; Philipp Saiko; Michael Grusch; Thomas Szekeres; Monika Fritzer-Szekeres; Walter Jäger; Georg Krupitza; Afschin Soleiman
Pro- and anticarcinogenic mechanisms of piceatannol are activated dose dependently in MCF-7 breast cancer cells.
Carcinogenesis 2010;31(12):2074-81.
2010: Verena Paulitschke; Nikolaus Schicher; Thomas Szekeres; Walter Jäger; Leonilla Elbling; Angelika B Riemer; Otto Scheiner; Golakoti Trimurtulu; Somepalli Venkateswarlu; Mario Mikula; Alexander Swoboda; Edda Fiebiger; Christopher Gerner; Hubert Pehamberger; Rainer Kunstfeld
3,3',4,4',5,5'-hexahydroxystilbene impairs melanoma progression in a metastatic mouse model.
The Journal of investigative dermatology 2010;130(6):1668-79.
2010: Sibylle Madlener; Philipp Saiko; C Vonach; K Viola; Nicole Huttary; N Stark; R Popescu; M Gridling; N T-P Vo; Irene Herbacek; A Davidovits; B Giessrigl; S Venkateswarlu; Silvana Geleff; Walter Jäger; Michael Grusch; Dontscho Kerjaschki; Wolfgang Mikulits; T Golakoti; Monika Fritzer-Szekeres; Thomas Szekeres; Georg Krupitza
Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro.
British journal of cancer 2010;102(9):1361-70.
2010: Michaela Miksits; Katrin Wlcek; Martin Svoboda; Theresia Thalhammer; Isabella Ellinger; Gabriele Stefanzl; Charles N Falany; Thomas Szekeres; Walter Jaeger
Expression of sulfotransferases and sulfatases in human breast cancer: impact on resveratrol metabolism.
Cancer letters 2010;289(2):237-45.
2010: Michaela Miksits; Alexandra Maier-Salamon; Thanh Phuong Nha Vo; Michael Sulyok; Rainer Schuhmacher; Thomas Szekeres; Walter Jäger
Glucuronidation of piceatannol by human liver microsomes: major role of UGT1A1, UGT1A8 and UGT1A10.
The Journal of pharmacy and pharmacology 2010;62(1):47-54.
2010: Ali Ozmen; Sibylle Madlener; Sabine Bauer; Stanimira Krasteva; Caroline Vonach; Benedikt Giessrigl; Manuela Gridling; Katharina Viola; Nicole Stark; Philipp Saiko; Barbara Michel; Monika Fritzer-Szekeres; Thomas Szekeres; Tülay Askin-Celik; Liselotte Krenn; Georg Krupitza
In vitro anti-leukemic activity of the ethno-pharmacological plant Scutellaria orientalis ssp. carica endemic to western Turkey.
Phytomedicine : international journal of phytotherapy and phytopharmacology 2010;17(1):55-62.
2009: Nicole Stark; Manuela Gridling; Sibylle Madlener; Sabine Bauer; Andreas Lackner; Ruxandra Popescu; Rene Diaz; Foster M Tut; Thanh-Phuong Nha Vo; Caroline Vonach; Benedikt Giessrigl; Philipp Saiko; Michael Grusch; Monika Fritzer-Szekeres; Thomas Szekeres; Brigitte Kopp; Richard Frisch; Georg Krupitza
A polar extract of the Maya healing plant Anthurium schlechtendalii (Aracea) exhibits strong in vitro anticancer activity.
International journal of molecular medicine 2009;24(4):513-21.
2009: Ali Ozmen; Sabine Bauer; Manuela Gridling; Judith Singhuber; Stanimira Krasteva; Sibylle Madlener; Than Phuong Nha Vo; Nicole Stark; Philipp Saiko; Monika Fritzer-Szekeres; Thomas Szekeres; Tülay Askin-Celik; Liselotte Krenn; Georg Krupitza
In vitro anti-neoplastic activity of the ethno-pharmaceutical plant Hypericum adenotrichum Spach endemic to Western Turkey.
Oncology reports 2009;22(4):845-52.
2009: Astrid Bernhaus; Maria Ozsvar-Kozma; Philipp Saiko; Margit Jaschke; Andreas Lackner; Michael Grusch; Zsuzsanna Horvath; Sibylle Madlener; Georg Krupitza; Norbert Handler; Thomas Erker; Walter Jaeger; Monika Fritzer-Szekeres; Thomas Szekeres
Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.
Investigational new drugs 2009;27(5):393-401.
2009: Michaela Miksits; Katrin Wlcek; Martin Svoboda; Olaf Kunert; Ernst Haslinger; Theresia Thalhammer; Thomas Szekeres; Walter Jäger
Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells.
Planta medica 2009;75(11):1227-30.
2009: Petra Heffeter; A Popovic-Bijelic; Philipp Saiko; R Dornetshuber; U Jungwirth; Nina Voevodskaya; D Biglino; Michael A Jakupec; Leonilla Elbling; Michael Micksche; Thomas Szekeres; Bernhard K Keppler; Astrid Gräslund; Walter Berger
Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772).
Current cancer drug targets 2009;9(5):595-607.
2009: Manuela Gridling; Nicole Stark; Sibylle Madlener; Andreas Lackner; Ruxandra Popescu; Birgit Benedek; Rene Diaz; Foster M Tut; Thanh Phuong Nha Vo; Daniela Huber; Michaela Gollinger; Philipp Saiko; Ali Ozmen; Wilhelm Mosgoeller; Rainer de Martin; Ruth Eytner; Karl-Heinz Wagner; Michael Grusch; Monika Fritzer-Szekeres; Thomas Szekeres; Brigitte Kopp; Richard Frisch; Georg Krupitza
In vitro anti-cancer activity of two ethno-pharmacological healing plants from Guatemala Pluchea odorata and Phlebodium decumanum.
International journal of oncology 2009;34(4):1117-28.
2009: Philipp Saiko; Maria Ozsvar-Kozma; Geraldine Graser; Andreas Lackner; Michael Grusch; Sibylle Madlener; Georg Krupitza; Walter Jaeger; Mate Hidvegi; Ram P Agarwal; Monika Fritzer-Szekeres; Thomas Szekeres
Avemar, a nontoxic fermented wheat germ extract, attenuates the growth of sensitive and 5-FdUrd/Ara-C cross-resistant H9 human lymphoma cells through induction of apoptosis.
Oncology reports 2009;21(3):787-91.
2009: Astrid Bernhaus; Monika Fritzer-Szekeres; Michael Grusch; Philipp Saiko; Georg Krupitza; Somepalli Venkateswarlu; Golakoti Trimurtulu; Walter Jaeger; Thomas Szekeres
Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells.
Cancer letters 2009;274(2):299-304.
2009: Michaela Miksits; Michael Sulyok; Rainer Schuhmacher; Thomas Szekeres; Walter Jäger
In-vitro sulfation of piceatannol by human liver cytosol and recombinant sulfotransferases.
The Journal of pharmacy and pharmacology 2009;61(2):185-91.
2008: Monika Fritzer-Szekeres; Ivo Savinc; Zsuzsanna Horvath; Philipp Saiko; Michael Pemberger; Geraldine Graser; Astrid Bernhaus; Maria Ozsvar-Kozma; Michael Grusch; Walter Jaeger; Thomas Szekeres
Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells--synergism with Ara-C.
International journal of oncology 2008;33(4):887-92.
2008: Christopher Adlbrecht; Spyridoula Kommata; Martin Hülsmann; Thomas Szekeres; Christian Bieglmayer; Guido Strunk; Georgios Karanikas; Rudolf Berger; Deddo Mörtl; Kurt Kletter; Gerald Maurer; Irene M Lang; Richard Pacher
Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume.
European heart journal 2008;29(19):2343-50.
2008: Marek Murias; Michal W Luczak; Anna Niepsuj; Violetta Krajka-Kuzniak; Malgorzata Zielinska-Przyjemska; Pawel P Jagodzinski; Walter Jäger; Thomas Szekeres; Jadwiga Jodynis-Liebert
Cytotoxic activity of 3,3',4,4',5,5'-hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase.
Toxicology in vitro : an international journal published in association with BIBRA 2008;22(5):1361-70.
2008: Loredana Cappellacci; Palmarisa Franchetti; Patrizia Vita; Riccardo Petrelli; Antonio Lavecchia; Hiremagalur N Jayaram; Philipp Saiko; Geraldine Graser; Thomas Szekeres; Mario Grifantini
Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives.
Journal of medicinal chemistry 2008;51(14):4260-9.
2008: Philipp Saiko; Michael Pemberger; Zsuzsanna Horvath; Ivo Savinc; Michael Grusch; Norbert Handler; Thomas Erker; Walter Jaeger; Monika Fritzer-Szekeres; Thomas Szekeres
Novel resveratrol analogs induce apoptosis and cause cell cycle arrest in HT29 human colon cancer cells: inhibition of ribonucleotide reductase activity.
Oncology reports 2008;19(6):1621-6.
2008: Alexandra Maier-Salamon; Birgit Hagenauer; Gottfried Reznicek; Thomas Szekeres; Theresia Thalhammer; Walter Jäger
Metabolism and disposition of resveratrol in the isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides.
Journal of pharmaceutical sciences 2008;97(4):1615-28.
2008: Marek Murias; Michaela Miksits; Sylvia Aust; Margit Spatzenegger; Theresia Thalhammer; Thomas Szekeres; Walter Jaeger
Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition.
Cancer letters 2008;261(2):172-82.
2008: Yvonne Bader; Sibylle Madlener; Stephan Strasser; Susanne Maier; Philipp Saiko; Nicole Stark; Ruxandra Popescu; Daniela Huber; Michaela Gollinger; Thomas Erker; Norbert Handler; Akos Szakmary; Walter Jäger; Brigitte Kopp; Ioannis K Tentes; Monika Fritzer-Szekeres; Georg Krupitza; Thomas Szekeres
Stilbene analogues affect cell cycle progression and apoptosis independently of each other in an MCF-7 array of clones with distinct genetic and chemoresistant backgrounds.
Oncology reports 2008;19(3):801-10.
2008: Yvonne Bader; Johannes Hartmann; Zsuzsanna Horvath; Philipp Saiko; Michael Grusch; Sibylle Madlener; Susanne Maier; Leopold Oehler; Monika Fritzer-Szekeres; Nicole Heller; Rudolf-Giesbert Alken; Georg Krupitza; Thomas Szekeres
Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines.
Cancer letters 2008;259(2):231-9.
2008: Philipp Saiko; Akos Szakmary; Walter Jaeger; Thomas Szekeres
Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?
Mutation research 2008;658(1-2):68-94.
2007: Carina Zorn; Thomas Szekeres; Mohammad Keilani; Veronika Fialka-Moser; Richard Crevenna
Effects of neuromuscular electrical stimulation of the knee extensor muscles on muscle soreness and different serum parameters in young male athletes: preliminary data.
British journal of sports medicine 2007;41(12):914-6.
2007: Philipp Saiko; Maria Ozsvar-Kozma; Astrid Bernhaus; Margit Jaschke; Geraldine Graser; Andreas Lackner; Michael Grusch; Zsuzsanna Horvath; Sibylle Madlener; Georg Krupitza; Norbert Handler; Thomas Erker; Walter Jaeger; Monika Fritzer-Szekeres; Thomas Szekeres
N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine.
International journal of oncology 2007;31(5):1261-6.
2007: Brigitte Meyer; Martin Huelsmann; Paul Wexberg; Georg Delle-Karth; Rudolf Berger; Deddo Moertl; Thomas Szekeres; Richard Pacher; Gottfried Heinz
N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.
Critical care medicine 2007;35(10):2268-73.
2007: Zsuzsanna Horvath; Sybille Marihart-Fazekas; Philipp Saiko; Michael Grusch; Mehmet Ozsüy; Mike Harik; Norbert Handler; Thomas Erker; Walter Jaeger; Monika Fritzer-Szekeres; Bob Djavan; Thomas Szekeres
Novel resveratrol derivatives induce apoptosis and cause cell cycle arrest in prostate cancer cell lines.
Anticancer research 2007;27(5A):3459-64.
2007: Philipp Saiko; Maria Ozsvar-Kozma; Sibylle Madlener; Astrid Bernhaus; Andreas Lackner; Michael Grusch; Zsuzsanna Horvath; Georg Krupitza; Walter Jaeger; Kirsten Ammer; Monika Fritzer-Szekeres; Thomas Szekeres
Avemar, a nontoxic fermented wheat germ extract, induces apoptosis and inhibits ribonucleotide reductase in human HL-60 promyelocytic leukemia cells.
Cancer letters 2007;250(2):323-8.
2007: Sibylle Madlener; Christoph Illmer; Zsuzsanna Horvath; Philipp Saiko; Annemarie Losert; Irene Herbacek; Michael Grusch; Howard L Elford; Georg Krupitza; Astrid Bernhaus; Monika Fritzer-Szekeres; Thomas Szekeres
Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells.
Cancer letters 2007;245(1-2):156-62.
2007: Peter Rauko; Ladislav Novotny; Michal Mego; Philipp Saiko; Herbert Schott; Thomas Szekeres
In vitro and in vivo antileukemic effect of novel dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.
Neoplasma 2007;54(1):68-74.
2006: Stephan Strasser; Susanne Maier; Christina Leisser; Philipp Saiko; Sibylle Madlener; Yvonne Bader; Astrid Bernhaus; Marieta Gueorguieva; Susanne Richter; Robert M Mader; Józefa Wesierska-Gadek; Herbert Schott; Thomas Szekeres; Monika Fritzer-Szekeres; Georg Krupitza
5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2.
Differentiation; research in biological diversity 2006;74(9-10):488-98.
2006: Zsuzsanna Horvath; Marek Murias; Philipp Saiko; Thomas Erker; Norbert Handler; Sibylle Madlener; Walter Jaeger; Michael Grusch; Monika Fritzer-Szekeres; Georg Krupitza; Thomas Szekeres
Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells.
Experimental hematology 2006;34(10):1377-84.
2006: Alexandra Maier-Salamon; Birgit Hagenauer; Michael Wirth; Franz Gabor; Thomas Szekeres; Walter Jäger
Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites.
Pharmaceutical research 2006;23(9):2107-15.
2006: Zdenka Ovesná; Katarína Kozics; Yvonne Bader; Philipp Saiko; Norbert Handler; Thomas Erker; Thomas Szekeres
Antioxidant activity of resveratrol, piceatannol and 3,3',4,4',5,5'-hexahydroxy-trans-stilbene in three leukemia cell lines.
Oncology reports 2006;16(3):617-24.
2006: Susanne Maier; Stephan Strasser; Philipp Saiko; Christina Leisser; Soleman Sasgary; Michael Grusch; Sibylle Madlener; Yvonne Bader; Johannes Hartmann; Herbert Schott; Robert M Mader; Thomas Szekeres; Monika Fritzer-Szekeres; Georg Krupitza
Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC.
Apoptosis : an international journal on programmed cell death 2006;11(3):427-40.
2006: Ladislav Novotny; Peter Rauko; Jan Liska; Howard L Elford; Thomas Szekeres
Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
Cancer letters 2006;233(1):178-84.
2006: Zsuzsanna Horvath; Philipp Saiko; Christoph Illmer; Sibylle Madlener; Thomas Hoechtl; Wolfgang Bauer; Thomas Erker; Walter Jaeger; Monika Fritzer-Szekeres; Thomas Szekeres
Resveratrol, an ingredient of wine, acts synergistically with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
Nucleosides, nucleotides & nucleic acids 2006;25(9-11):1019-24.
2006: Philipp Saiko; Zsuzsanna Horvath; Marek Murias; Norbert Handler; Walter Jaeger; Thomas Erker; Monika Fritzer-Szekeres; Thomas Szekeres
Antitumor effects of 3,3',4,4',5,5'-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells.
Nucleosides, nucleotides & nucleic acids 2006;25(9-11):1013-7.
2005: Michaela Miksits; Alexandra Maier-Salamon; Sylvia Aust; Theresia Thalhammer; Gottfried Reznicek; Olaf Kunert; Ernst Haslinger; Thomas Szekeres; Walter Jaeger
Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1.
Xenobiotica; the fate of foreign compounds in biological systems 2005;35(12):1101-19.
2005: Johannes Hartmann; Yvonne Bader; Zsuzsanna Horvath; Philipp Saiko; Michael Grusch; Christoph Illmer; Sibylle Madlener; Monika Fritzer-Szekeres; Nicole Heller; Rudolf-Giesbert Alken; Thomas Szekeres
Effects of heavy water (D2O) on human pancreatic tumor cells.
Anticancer research 2005;25(5):3407-11.
2005: Palmarisa Franchetti; Loredana Cappellacci; Michela Pasqualini; Riccardo Petrelli; Patrizia Vita; Hiremagalur N Jayaram; Zsuzsanna Horvath; Thomas Szekeres; Mario Grifantini
Antitumor activity of C-methyl-beta-D-ribofuranosyladenine nucleoside ribonucleotide reductase inhibitors.
Journal of medicinal chemistry 2005;48(15):4983-9.
2005: Philipp Saiko; Zsuzsanna Horvath; Christoph Illmer; Sibylle Madlener; Wolfgang Bauer; Thomas Hoechtl; Natascha Erlach; Michael Grusch; Georg Krupitza; Robert M Mader; Walter Jaeger; Herbert Schott; Ram P Agarwal; Monika Fritzer-Szekeres; Thomas Szekeres
Cytotoxic effects of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine in cross-resistant H9 human lymphoma cells.
Leukemia research 2005;29(7):785-91.
2005: Ladislav Novotny; Thomas Szekeres
Recent developments in cancer chemotherapy oriented towards new targets.
Expert opinion on therapeutic targets 2005;9(2):343-57.
2005: Marek Murias; Walter Jäger; Norbert Handler; Thomas Erker; Zsuzsanna Horvath; Thomas Szekeres; Hans Nohl; Lars Gille
Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship.
Biochemical pharmacology 2005;69(6):903-12.
2005: Thomas Szekeres; Alexander Haushofer
Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation.
Pharmacogenomics 2005;6(2):163-8.
2005: Zsuzsanna Horvath; Philipp Saiko; Christoph Illmer; Sibylle Madlener; Thomas Hoechtl; Wolfgang Bauer; Thomas Erker; Walter Jaeger; Monika Fritzer-Szekeres; Thomas Szekeres
Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
Experimental hematology 2005;33(3):329-35.
2005: Christoph Illmer; Sibylle Madlener; Zsuzsanna Horvath; Philipp Saiko; Annemarie Losert; Irene Herbacek; Michael Grusch; Georg Krupitza; Monika Fritzer-Szekeres; Thomas Szekeres
Immunologic and biochemical effects of the fermented wheat germ extract Avemar.
Experimental biology and medicine (Maywood, N.J.) 2005;230(2):144-9.
2005: Philipp Saiko; Zsuzsanna Horvath; Walter Jaeger; Herbert Schott; Monika Fritzer-Szekeres; Thomas Szekeres
Heterodinucleoside phosphates of 5-fluorodeoxyuridine and arabinofuranosylcytosine--new drugs in cancer chemotherapy?
In vivo (Athens, Greece) 2005;19(1):205-14.
2004: Marek Murias; Norbert Handler; Thomas Erker; Karin Pleban; Gerhard F Ecker; Philipp Saiko; Thomas Szekeres; Walter Jäger
Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship.
Bioorganic & medicinal chemistry 2004;12(21):5571-8.
2004: Wolfgang Bauer; Zsuzsanna Horvath; Thomas Höchtl; Philipp Saiko; Doris Karl; Monika Fritzer-Szekeres; Thomas Szekeres
Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells.
Nucleosides, nucleotides & nucleic acids 2004;23(8-9):1541-4.
2004: Zsuzsanna Horvath; Wolfgang Bauer; Thomas Hoechtl; Philipp Saiko; Monika Fritzer-Szekeres; Tarik Tihan; Thomas Szekeres
Combination chemotherapy of BCNU and Didox acts synergystically in 9L glioma cells.
Nucleosides, nucleotides & nucleic acids 2004;23(8-9):1531-5.
2004: Philipp Saiko; Wolfgang Bauer; Zsuzsanna Horvath; Thomas Hoechtl; Michael Grusch; Christoph Illmer; Sibylle Madlener; Georg Krupitza; Robert M Mader; Herbert Schott; Monika Fritzer-Szekeres; Thomas Szekeres
Cytotoxic and apoptotic effects of novel heterodinucleoside phosphates consisting of 5-fluorodeoxyuridine and Ara-C in human cancer cell lines.
Nucleosides, nucleotides & nucleic acids 2004;23(8-9):1507-11.
2004: Philipp Saiko; Zsuzsanna Horvath; Wolfgang Bauer; Thomas Hoechtl; Michael Grusch; Georg Krupitza; Peter Rauko; Robert M Mader; Walter Jaeger; Herbert Schott; Ladislav Novotny; Monika Fritzer-Szekeres; Thomas Szekeres
In vitro and in vivo antitumor activity of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.
International journal of oncology 2004;25(2):357-64.
2004: Zsuzsanna Horvath; Thomas Höchtl; Wolfgang Bauer; Monika Fritzer-Szekeres; Howard L Elford; Thomas Szekeres; Tarik Tihan
Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells.
Cancer chemotherapy and pharmacology 2004;54(2):139-45.
2004: Thomas Höchtl; Zsuzsanna Horvath; Wolfgang Bauer; Doris Karl; Philipp Saiko; Howard L Elford; Monika Fritzer-Szekeres; Thomas Szekeres
Biochemical modulation of Ara-C effects by amidox, an inhibitor of ribonucleotide reductase in HL-60 promyelocytic human leukemia cells.
Life sciences 2004;74(9):1071-80.
2003: Peter Rauko; Wolfgang Bauer; Zsuzsanna Horvath; Thomas Höchtl; Philipp Saiko; Doris Karl; Herbert Schott; Monika Fritzer-Szekeres; Ladislav Novotny; Thomas Szekeres
Combination effects of Ara-C and 5-fluorodeoxyuridine against leukemia cells in vitro and in mice.
Anticancer research 2003;23(5A):3841-6.
2003: Christian Lhotka; Thomas Szekeres; Ilse Steffan; Klaus Zhuber; Karl A Zweymüller
Four-year study of cobalt and chromium blood levels in patients managed with two different metal-on-metal total hip replacements.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2003;21(2):189-95.
2002: Monika Fritzer-Szekeres; Alexandra Salamon; Michael Grusch; Zsuzsanna Horvath; Thomas Höchtl; Richard Steinbrugger; Walter Jäger; Georg Krupitza; Howard L Elford; Thomas Szekeres
Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.
Biochemical pharmacology 2002;64(3):481-5.
2002: Thomas Szekeres; Ladislav Novotny
New targets and drugs in cancer chemotherapy.
Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2002;11(3):117-25.
2002: Walter Jäger; Alexandra Salamon; Thomas Szekeres
Metabolism of the novel IMP dehydrogenase inhibitor benzamide riboside.
Current medicinal chemistry 2002;9(7):781-6.
2002: Ladislav Novotny; Peter Rauko; Joel A Yalowitz; Thomas Szekeres
Antitumor activity of benzamide riboside in vitro and in vivo.
Current medicinal chemistry 2002;9(7):773-9.
2002: Thomas Szekeres; Jan Sedlak; Ladislav Novotny
Benzamide riboside, a recent inhibitor of inosine 5'-monophosphate dehydrogenase induces transferrin receptors in cancer cells.
Current medicinal chemistry 2002;9(7):759-64.
2002: Michael Grusch; Doris Polgar; S Gfatter; Katharina Leuhuber; Simone Huettenbrenner; Christina Leisser; Gerhard Fuhrmann; Fekadu Kassie; Herta Steinkellner; K Smid; GJ Peters; Hiremagalur N Jayaram; Waltraud Klepal; Thomas Szekeres; Siegfried Knasmüller; Georg Krupitza
Maintenance of ATP favours apoptosis over necrosis triggered by benzamide riboside.
Cell death and differentiation 2002;9(2):169-78.
2001: Alexandra Salamon; Birgit Hagenauer; Theresia Thalhammer; Thomas Szekeres; K Krohn; Hiremagalur N Jayaram; Walter Jäger
Metabolism and disposition of the novel antileukaemic drug, benzamide riboside, in the isolated perfused rat liver.
Life sciences 2001;69(21):2489-502.
2001: Michael Grusch; Monika Fritzer-Szekeres; Gerhard Fuhrmann; Georg Rosenberger; C Luxbacher; Howard L Elford; K Smid; GJ Peters; Thomas Szekeres; Georg Krupitza
Activation of caspases and induction of apoptosis by novel ribonucleotide reductase inhibitors amidox and didox.
Experimental hematology 2001;29(5):623-32.
2001: Peter Rauko; Ladislav Novotny; I Dovinova; L Hunakova; Thomas Szekeres; H N Jayaram
Antitumor activity of benzamide riboside and its combination with cisplatin and staurosporine.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2001;12(4):387-94.
2000: Kamran Gharehbaghi; Thomas Szekeres; Joel A Yalowitz; Monika Fritzer-Szekeres; Y G Pommier; Hiremagalur N Jayaram
Sensitizing human colon carcinoma HT-29 cells to cisplatin by cyclopentenylcytosine, in vitro and in vivo.
Life sciences 2000;68(1):1-11.
2000: Georg Rosenberger; Gerhard Fuhrmann; Michael Grusch; Sandra Fassl; Howard L Elford; K Smid; GJ Peters; Thomas Szekeres; Georg Krupitza
The ribonucleotide reductase inhibitor trimidox induces c-myc and apoptosis of human ovarian carcinoma cells.
Life sciences 2000;67(26):3131-42.
2000: Ahmad Hamwi; A Salomon; Richard Steinbrugger; Monika Fritzer-Szekeres; Walter Jäger; Thomas Szekeres
Cyclosporine metabolism in patients after kidney, bone marrow, heart-lung, and liver transplantation in the early and late posttransplant periods.
American journal of clinical pathology 2000;114(4):536-43.
2000: Alexandra Salamon; E Vielnascher; Birgit Hagenauer; Thomas Szekeres; M Szekeres-Fritzer; Theresia Thalhammer; Walter Jäger
Metabolism of the new ribonucleotide reductase inhibitor amidox in the isolated perfused rat liver.
Anticancer research 2000;20(5B):3521-6.
2000: Monika Fritzer-Szekeres; Michael Grusch; C Luxbacher; S Horvath; Georg Krupitza; Howard L Elford; Thomas Szekeres
Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells.
Experimental hematology 2000;28(8):924-30.
2000: Kamran Gharehbaghi; Andreas Kubin; Michael Grusch; E Gharehbaghi-Schnell; Franz Wierrani; Hiremagalur N Jayaram; W Grunberger; Thomas Szekeres
Photodynamic action of meta-tetrahydroxyphenylchlorin (mTHPC) on an ovarian cancer cell line.
Anticancer research 2000;20(4):2647-52.
2000: Ahmad Hamwi; Mario Veitl; G Maenner; Harald Vogelsang; Thomas Szekeres
Pancreatic elastase 1 in stool: variations within one stool passage and individual changes from day to day.
Wiener klinische Wochenschrift 2000;112(1):32-5.
2000: Monika Fritzer-Szekeres; C Luxbacher; Zsuzsanna Horvath; Michael Grusch; Georg Krupitza; Howard L Elford; Thomas Szekeres
Apoptosis-inducing cleavage of caspases by trimidox, an inhibitor of ribonucleotide reductase.
Advances in experimental medicine and biology 2000;486():125-30.
1999: Ahmad Hamwi; Mario Veitl; G Männer; Katharina Ruzicka; C Schweiger; Thomas Szekeres
Evaluation of four automated methods for determination of whole blood cyclosporine concentrations.
American journal of clinical pathology 1999;112(3):358-65.
1999: Michael Grusch; Georg Rosenberger; Gerhard Fuhrmann; K Braun; B Titscher; Thomas Szekeres; M Fritzer-Skekeres; G Oberhuber; K Krohn; M Hengstschlaeger; Georg Krupitza; Hiremagalur N Jayaram
Benzamide riboside induces apoptosis independent of Cdc25A expression in human ovarian carcinoma N.1 cells.
Cell death and differentiation 1999;6(8):736-44.
1999: Kamran Gharehbaghi; W Zhen; Monika Fritzer-Szekeres; Thomas Szekeres; Hiremagalur N Jayaram
Studies on the antitumor activity and biochemical actions of cyclopentenyl cytosine against human colon carcinoma HT-29 in vitro and in vivo.
Life sciences 1999;64(2):103-12.
1998: Christian Lhotka; Thomas Szekeres; Monika Fritzer-Szekeres; G Schwarz; Ilse Steffan; M Maschke; G Dubsky; Michaela Kremser; Karl A Zweymüller
Are allergic reactions to skin clips associated with delayed wound healing?
American journal of surgery 1998;176(4):320-3.
1998: Monika Fritzer-Szekeres; H J Blom; G H Boers; Thomas Szekeres; Barbara Lubec
Growth promotion by homocysteine but not by homocysteic acid: a role for excessive growth in homocystinuria or proliferation in hyperhomocysteinemia?
Biochimica et biophysica acta 1998;1407(1):1-6.
1998: LE Hunáková; Jozef Duraj; D Romanová; Ladislav Novotný; Ján Sedlák; M R Kelley; Thomas Szekeres; H N Jayaram; B Chorváth
Staurosporine enhanced benzamide riboside-induced apoptosis in human multidrug-resistant promyelocytic leukemia cells (HL-60/VCR) in vitro.
Neoplasma 1998;45(4):204-9.
1998: Monika Fritzer-Szekeres; Ladislav Novotny; D Romanova; R Göbl; Jan Sedlak; A Vachalkova; Peter Rauko; Howard L Elford; Thomas Szekeres
Enhanced effects of adriamycin by combination with a new ribonucleotide reductase inhibitor, trimidox, in murine leukemia.
Life sciences 1998;63(7):545-52.
1998: Monika Fritzer-Szekeres; Ladislav Novotny; A Vachalkova; R Göbl; Howard L Elford; Thomas Szekeres
Iron binding capacity of didox (3,4 dihydroxybenzohydroxamic acid) and amidox (3,4 dihydroxybenzamidoxime) two inhibitors of the enzyme ribonucleotide reductase.
Advances in experimental medicine and biology 1998;431():599-604.
1997: Peter Rauko; D Romanova; Eva Miadokova; K Macakova; Ladislav Novotny; Howard L Elford; Thomas Szekeres
DNA-protective activity of new ribonucleotide reductase inhibitors.
Anticancer research 1997;17(5A):3437-40.
1997: E Vielnascher; D Romanová; Ladislav Novotný; Thomas Szekeres; H L Elfort; Theresia Thalhammer; Walter Jäger
Simultaneous determination of the new anticancer agent amidox and its metabolites in rat bile and plasma by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 1997;696(2):267-74.
1997: D Romanova; A Vachalkova; Thomas Szekeres; Howard L Elford; Ladislav Novotny
The new inhibitors of ribonucleotide reductase--comparison of some physico-chemical properties.
Journal of pharmaceutical and biomedical analysis 1997;15(7):951-6.
1997: Thomas Szekeres; Monika Fritzer-Szekeres; Howard L Elford
The enzyme ribonucleotide reductase: target for antitumor and anti-HIV therapy.
Critical reviews in clinical laboratory sciences 1997;34(6):503-28.
1997: Monika Fritzer-Szekeres; Ladislav Novotny; A Vachalkova; G Findenig; Howard L Elford; Thomas Szekeres
Iron binding capacity of didox (3,4-dihydroxybenzohydroxamic acid) and amidox (3,4-dihydroxybenzamidoxime) new inhibitors of the enzyme ribonucleotide reductase.
Life sciences 1997;61(22):2231-7.
1996: M Fritzer; Thomas Szekeres; V Szüts; H N Jarayam; Hans Goldenberg
Cytotoxic effects of a doxorubicin-transferrin conjugate in multidrug-resistant KB cells.
Biochemical pharmacology 1996;51(4):489-93.
1996: Georg Krupitza; S Grill; Hanna Harant; Wolfgang Hulla; Thomas Szekeres; Heinz Huber; Christian Dittrich
Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells.
British journal of cancer 1996;73(4):433-8.
1996: G Findenig; R M Mader; Monika Fritzer-Szekeres; Guenther G Steger; W Jaeger; Thomas Szekeres
Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine.
Oncology research 1996;8(5):189-96.
1996: H J Schön; M Grgurin; Thomas Szekeres; B Schurz
A new mode of treatment of human papilloma virus associated anogenital lesions using a nonsteroid estrogen analogue.
Wiener klinische Wochenschrift 1996;108(2):45-7.
1995: Thomas Szekeres; E Vielnascher; Ladislav Novotny; A Vachalkova; M Fritzer; G Findenig; R Göbl; Howard L Elford; Hans Goldenberg
Iron binding capacity of trimidox (3,4,5-trihydroxybenzamidoxime), a new inhibitor of the enzyme ribonucleotide reductase.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1995;33(11):785-9.
1995: Georg Krupitza; Hanna Harant; Elisabeth Dittrich; Thomas Szekeres; Heinz Huber; Christian Dittrich
Sodium butyrate inhibits c-myc splicing and interferes with signal transduction in ovarian carcinoma cells.
Carcinogenesis 1995;16(5):1199-205.
1995: G Findenig; E Vielnascher; R Göbl; Monika Fritzer-Szekeres; Thomas Szekeres
[The ribonucleotide reductase enzyme as a target for enzyme-directed chemotherapy effects of trimidox (3,4,5-trihydroxybenzohydroxamidoxim), a new inhibitor of ribonucleotide reductases].
Wiener klinische Wochenschrift 1995;107(22):694-7.
1994: Thomas Szekeres; M Fritzer; Herbert Strobl; Kamran Gharehbaghi; G Findenig; Howard L Elford; C Lhotka; H J Schoen; Hiremagalur N Jayaram
Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cells.
Blood 1994;84(12):4316-21.
1994: Kamran Gharehbaghi; A Sreenath; Z Hao; KD Paull; Thomas Szekeres; D A Cooney; K Krohn; Hiremagalur N Jayaram
Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin.
Biochemical pharmacology 1994;48(7):1413-9.
1994: Thomas Szekeres; Kamran Gharehbaghi; M Fritzer; M Woody; Arun Srivastava; B van't Riet; Hiremagalur N Jayaram; Howard L Elford
Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase.
Cancer chemotherapy and pharmacology 1994;34(1):63-6.
1994: Thomas Szekeres; M Fritzer; H J Schön; G Findenig; C Lhotka
[Synergistic cytotoxic effects of chemotherapy in colon tumor cells by simultaneous inhibition of de novo and salvage energy metabolism pathways].
Wiener klinische Wochenschrift 1994;106(14):459-63.
1993: Thomas Szekeres; K Schuchter; Peter Chiba; Gabriele Ressmann; C Lhotka; Kamran Gharehbaghi; S M Szalay; K Pillwein
Synergistic action of tiazofurin with hypoxanthine and allopurinol in human neuroectodermal tumor cell lines.
Biochemical pharmacology 1993;46(11):1903-7.
1993: K Pillwein; K Schuchter; G Ressmańn; Kamran Gharehbaghi; A Knoflach; B Cermak; Hiremagalur N Jayaram; S M Szalay; Thomas Szekeres; Peter Chiba
Cytotoxicity, differentiating activity and metabolism of tiazofurin in human neuroblastoma cells.
International journal of cancer. Journal international du cancer 1993;55(1):92-5.
1993: M Fritzer; Kamran Gharehbaghi; K Pillwein; Peter Chiba; Hans Goldenberg; Thomas Szekeres
GM-CSF: modulation of biochemical and cytotoxic effects of tiazofurin in HL-60 cells.
British journal of haematology 1993;84(3):552-4.
1993: Thomas Szekeres; Erika Artner-Dworzak; B Puschendorf; M Fritzer; M Havel; A Gassner; L Fridrich
Correlation of atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in patients with heart disorders during rest and exercise.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1993;31(2):69-74.
1993: George Weber; R L Singhal; Margit Abonyi; N Prajda; Y Hata; Thomas Szekeres; A Yeh; Katherine Y Look
Regulation of deoxycytidine kinase activity and inhibition by DFDC.
Advances in enzyme regulation 1993;33():39-59.
1992: Thomas Szekeres; Y S Cho-Chung; George Weber
Action of tiazofurin and 8-Cl-cAMP in human colon and pancreatic cancer cells.
Cancer biochemistry biophysics 1992;13(2):67-74.
1992: M Fritzer; K Barabas; V Szüts; Alajos Bérczi; Thomas Szekeres; W Page Faulk; Hans Goldenberg
Cytotoxicity of a transferrin-adriamycin conjugate to anthracycline-resistant cells.
International journal of cancer. Journal international du cancer 1992;52(4):619-23.
1992: Thomas Szekeres; M Fritzer; K Pillwein; T Felzmann; Peter Chiba
Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin.
Life sciences 1992;51(16):1309-15.
1992: George Weber; H Nakamura; Y Natsumeda; Thomas Szekeres; M Nagai
Regulation of GTP biosynthesis.
Advances in enzyme regulation 1992;32():57-69.
1992: R L Singhal; Y A Yeh; Thomas Szekeres; George Weber
Increased deoxycytidine kinase activity in cancer cells and inhibition by difluorodeoxycytidine.
Oncology research 1992;4(11-12):517-22.
1991: Peter Chiba; Thomas Szekeres; W Jäger
Determination of pyrimidine deoxynucleoside triphosphates in leukaemia cell extracts containing 1-beta-D-arabinofuranosylcytosine triphosphate.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1991;29(6):385-9.
1991: George Weber; M Nagai; N Prajda; H Nakamura; Thomas Szekeres; Edith Olah
AZT: a biochemical response modifier of methotrexate and 5-fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells.
Cancer communications 1991;3(4):127-32.
1990: Peter Chiba; T Tihan; Thomas Szekeres; J Salamon; M Kraupp; R Eher; U Köller; Walter Knapp
Concordant changes of pyrimidine metabolism in blasts of two cases of acute myeloid leukemia after repeated treatment with ara-C in vivo.
Leukemia 1990;4(11):761-5.
1989: L Fridrich; Thomas Szekeres; E Hartter; F Schweighofer; A Gassner; A Laczkovic
Correlation between heart disorders and concentrations of directly measured atrial natriuretic peptide in plasma.
Clinical chemistry 1989;35(3):435-9.
1986: M Kraupp; R März; E Legenstein; B Knerer; Thomas Szekeres
Evaluation of radioimmunoassays: comparison of dose interpolation calculations by four parameter logistic and spline functions.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1986;24(12):1023-8.